$TirzepatidePriceGuide
Head-to-head comparison

Zepbound® vs Mounjaro®

Zepbound and Mounjaro are the same molecule (tirzepatide) from Eli Lilly — but differ in FDA indication, self-pay options, and cost. Here's the breakdown.

Released: · Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 10, 2026 · This page is informational and does not constitute medical advice.
 Zepbound®Mounjaro®
MakerEli LillyEli Lilly
Active ingredientTirzepatideTirzepatide
FDA indicationChronic weight management (+ OSA)Type 2 diabetes
MechanismDual GLP-1/GIPDual GLP-1/GIP
Self-pay / month$299–$449 (LillyDirect)~$900–$1,080 (retail/GoodRx)
Retail list~$1,086~$1,069–$1,080
Weight-loss useOn-labelOff-label

Pricing verified as of July 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.

Clinical model

Both contain tirzepatide and act on the same dual GLP-1/GIP pathway. Zepbound is FDA-approved for chronic weight management (and obstructive sleep apnea); Mounjaro is FDA-approved for type 2 diabetes. Using Mounjaro for weight loss is off-label.

Pharmacy & fulfillment

Both are manufactured by Eli Lilly. Zepbound has a dedicated LillyDirect self-pay vial program ($299–$449/mo within the 45-day refill window); Mounjaro does not, so cash-pay relies on retail and GoodRx (~$900–$1,080). For compounded tirzepatide cost context, see compounded tirzepatide cost (not FDA-approved).

Pros & trade-offs

Strengths and trade-offs

Zepbound®

Strengths
  • FDA-approved for weight management
  • Lower self-pay via LillyDirect ($299–$449)
  • Also approved for sleep apnea
Trade-offs
  • Self-pay requires 45-day refill window for best price
  • Still costlier than compounded cash-pay

Mounjaro®

Strengths
  • FDA-approved for type 2 diabetes
  • May be covered when prescribed for diabetes
Trade-offs
  • No dedicated self-pay program
  • Off-label for weight loss
  • Higher cash cost than Zepbound self-pay

Who each may be best for

Zepbound is the on-label brand choice for weight management with the cheaper self-pay route. Mounjaro is the on-label choice for type 2 diabetes. Same molecule either way; a licensed clinician decides what is appropriate.

Top pick · flat-rate compounded
$115/mo*
All doses one price · coaching included
See NexLife pricing →
FAQ

Questions

Are Zepbound and Mounjaro the same drug?

Both contain tirzepatide and work identically. The difference is FDA indication (Zepbound for weight, Mounjaro for type 2 diabetes) and the resulting pricing/coverage. See NexLife pricing

Which is cheaper for weight loss?

For weight management, Zepbound's LillyDirect self-pay ($299–$449/mo) is usually cheaper than cash-pay Mounjaro (~$900–$1,080/mo).

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.

Keep comparing

Related comparisons & cost guides